Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity

類似資料

• Fluoxetine inhibits the metabolism of tolterodine—pharmacokinetic implications and proposed clinical relevance
  著者:: Brynne, N, 等
  出版事項: (1999)
• Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole
  著者:: Brynne, N, 等
  出版事項: (1999)
• Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genes
  著者:: Dalén, P, 等
  出版事項: (2000)
• Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes
  著者:: Herrlin, Karin, 等
  出版事項: (2003)
• Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humans
  著者:: BÖTTIGER, Y., 等
  出版事項: (1996)